GeneDx Holdings Corp. cotiza a 65.65 USD y tiene una capitalización bursátil de $2.0B. En los últimos 12 meses ha facturado $454M con un margen de flujo de caja libre del 3.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, in…
| Periodo | 2026-10 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.01 | $-0.28 | $0.14 |
| Estimado | $0.07 | $-0.19 | $-0.02 | $0.12 |
| Sorpresa | — | +105.3% | -1300.0% | +16.7% |
| Métrica | WGS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 69.7% | 57.0% | +12.7% |
| Operating Margin | -3.1% | -38.6% | +35.6% |
| Net Margin | -4.9% | -33.6% | +28.6% |
| FCF Margin | 3.3% | -13.9% | +17.2% |
| ROE | -6.8% | -40.4% | +33.6% |
| ROA | -4.0% | -32.0% | +28.0% |
| Current Ratio | 2.46 | 2.84 | -0.38 |
| Debt / Equity | 0.18 | 0.28 | -0.10 |